Publisher

V

P

G

A

R

Volume : 03

Issue : 03

ISSN No. : 2584-2757

Volume : 03

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH

ROGANIDAN VIKRUTIVIGYAN PG ASSOCIATION

FOR PATHOLOGY AND RADIODIGNOSIS

Reg. No. : MAHA-703/16(NAG)

Issue

: 03

Year of Establishment – 2016

: https://doi.org/10.5281/zenodo.19613930

DOI

Impact Factor : 1.013

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH

Integrated Ayurveda-Jyotisha Framework For Hridrava: Classical Basis,

Therapeutic Rationale, And A Proposed Protocol For Clinical Validation

Dr.Pachore Shreyansh ¹, Dr.Wade Avinash², Dr.Vanganekar Namdev ³

¹Professor, Department of Rachana Sharir, Nootan Ayurvedic College and Research Centre, Sankalchand Patel

University, Visnagar, District Mahesana, Gujarat – 384315, India.

²Associate Professor, Department of Rognidan & Vikriti Vijnan, Nootan Ayurvedic College and Research Centre,

Sankalchand Patel University, Visnagar, District Mahesana, Gujarat – 384315, India.

³Vice Principal and Associate Professor, Department of Rasashastra evam Bhaishajya Kalpana, Nootan

Ayurvedic College and Research Centre, Sankalchand Patel University, Visnagar, District Mahesana, Gujarat –

384315, India.

Corresponding Author: Dr.Pachore Shreyansh

ORCID ID: 0009-0006-2661-9938

Article Info: Article Received on : 24/03/2026

Article Reviewed on: 13/04/2026

Article Published on : 15/04/2026

Cite this article as: - Pachore, S., Wade, A., & Vangnekar, N. (2026). Integrated Ayurveda-Jyotisha Framework For Hridrava:

Classical Basis, Therapeutic Rationale, And A Proposed Protocol For Clinical Validation. International Journal of Diagnostics And

Research, 3(3), 175–184. https://doi.org/10.5281/zenodo.19613930

Abstract

Background and Aim: Hridrava, understood in Ayurvedic literature as a functional cardiac symptom-complex

characterised by distressing palpitations and Vata aggravation in the Hridaya, is a clinically significant presentation

in the context of rising functional cardiovascular complaints linked to anxiety, autonomic dysregulation, and stress.

Classical Ayurvedic texts describe Hridaya as a vital seat of Prana and circulatory function, while Jyotisha literature

identifies Surya (Sun) as a principal significator of vitality and cardiac integrity. This article develops an integrative

Ayurveda-Jyotisha conceptual framework and proposes a clinical validation protocol.Methods: A systematic

analysis

of

primary

classical

Sanskrit

texts

was

undertaken,

including Charaka

Samhita (Chikitsa

Sthana 28/96), Sushruta

Samhita (Sharira

Sthana 4/31-35), Ashtanga

Hridaya (Nidana

Sthana 6), Brihat

Jataka (Varahamihira, Adhyaya 2/12), Brihat Parashara Hora Shastra (Adhyaya 12, 14), and Aditya Hridaya

Stotra (Valmiki Ramayana, Yuddha Kanda 107). Pharmacological and clinical literature relevant

to Shaliparni (Desmodium gangeticum) and Manikya Pishti (ruby calx) was also reviewed.Results: Textual evidence

supports solar-centric therapeutic rationale for Hridrava management, integrating Shaliparni Siddha

a

Dugdha (herbal milk preparation), Manikya Pishti (ruby mineral formulation), and Aditya Hridaya recitation as

conceptually aligned therapeutic elements. A Planetary Affliction Scoring System (0-12 scale) is proposed to

quantify Jyotisha-based cardiac vulnerability. A prospective, four-arm, randomised controlled trial design is outlined

for future clinical validation.Conclusion: An Ayurveda-Jyotisha integrated model for Hridrava is conceptually

grounded and methodologically testable. Rigorous clinical evaluation through blinded, controlled trial design,

pharmaceutical standardisation, and ethics-compliant protocol will be necessary to translate this framework into

evidence-based clinical practice.

Keywords: Hridrava; Hridaya; Ayurveda; Jyotisha; Shaliparni; Manikya Pishti; cardiac palpitations

Copyright @ : - Dr.Pachore Shreyansh Inter. J.Digno. and Research IJDRMSID0124 |ISSN :2584-2757

175

Volume : 03

Issue : 03

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH

epithet Amshumati connotes solar radiance),

Introduction :

and Aditya Hridaya Stotra (the solar heart-hymn

from the Valmiki Ramayana) — provides a

conceptually unified basis for an integrative

therapeutic model.The present article has three

objectives: (1) to review classical Ayurvedic

and Jyotisha foundations relevant to Hridrava; (2)

to articulate the therapeutic rationale for a solar-

centric intervention model; and (3) to outline a

prospective research protocol suitable for rigorous

clinical validation within the Indian Knowledge

Systems (IKS) research framework.

Functional cardiac disturbances — particularly

palpitations unaccompanied by structural cardiac

abnormality — represent a substantial proportion of

outpatient cardiovascular consultations. Patients

presenting with episodes of distressing heart

awareness, restlessness, sleep disruption, anxiety,

and breathlessness frequently receive a reassuring

normal investigation workup, yet continue to

experience symptoms that erode quality of life.

Biomedicine provides limited therapeutic pathways

for such functional presentations beyond anxiety

management and lifestyle modification.^[1]

Classical Ayurvedic Understanding Of Hridaya

And Hridrava :

Ayurveda offers a conceptually richer framework

for addressing such symptom-complexes through

the interconnected doctrines of Hridaya (the heart

Hridaya in Ayurvedic Anatomy and Physiology :

Hridaya occupies a position of cardinal importance

across all three principal classical Ayurvedic

compilations. Charaka Samhita (Sutra Sthana 30/3-

4) describes Hridaya as the root of Rasavaha

Srotas and the site of Prana residence, classifying

it as one of the three Paramardiya Marmas (most

as

a Pranayatana

), Vata

-

Pitta

Kapha

imbalance, Rasavaha Srotas dysfunction, and the

psychosomatic

continuum

[2,3,21]

linking

The Ayurvedic concept

Manas and Sharira.

of Hridrava — denoting distressing, irregular, or

forceful cardiac awareness — emerges from this

framework as a clinically meaningful entity

vital

structures)

alongside Basti and Shira.^[6]

Sushruta Samhita (Sharira Sthana 4/31-35) places

Hridaya at the centre of circulatory physiology,

describing it as the originating vessel from which

the Dhamani (vessels) distribute Rasa to the entire

amenable

to

herbal,

mineral,

dietary,

and

psychospiritual interventions.^[4]In parallel, Jyotisha

Shastra — the classical Indian science of planetary

body.^[7]Ashtanga

Hridaya (Nidana

Sthana 6)

astronomy

and

predictive

Sun)

interpretation

—

further elaborates the role of Sadhaka Pitta seated

in the Hridaya in governing mental clarity, volition,

and emotional equilibrium. This multidimensional

model — simultaneously anatomical, physiological,

and psychological — positions Hridaya not as a

simple mechanical pump but as a convergence

point of Prana, consciousness, and circulatory

identifies Surya (the

as the primary

significator of Atman, Prana, and vitality, and

specifically associates solar affliction with

disorders involving the heart and thoracic region.^[5]

This

convergence

between

Ayurveda

and Jyotisha around solar symbolism — evident in

the

therapeutic

use

of Manikya (ruby, Surya's

vitality.

multidimensional therapeutic responses.

Copyright @ : - Dr.Pachore Shreyansh Inter. J.Digno. and Research IJDRMSID0124 |ISSN :2584-2757

Pathology

here

therefore

demands

gemstone), Shaliparni

(whose

176

Volume : 03 Issue : 03

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]

Recent

pharmacological

investigations

have

Hridrava

Pathogenesis:

Hridroga, the broader category of heart disease, is

classified into five types in classical

texts: Vataja, Pittaja, Kaphaja, Tridoshaja,

—

Classification,

Aetiology,

and

confirmed

the cardioprotective

relevance

of Desmodium gangeticum. Mridula and Ansary

(2023) documented the cardioprotective secondary

metabolites of this plant, including alkaloids and

flavonoids demonstrating negative inotropic and

chronotropic properties in experimental models^.[11]

HPTLC fingerprinting, alkaloid quantification, and

and Krimija. Among these, Vataja Hridroga most

closely corresponds to the functional palpitation

complex. Features include spandana (throbbing)

, toda (pricking), shula (pain), kshobha (agitation),

bhrama (giddiness), and parva-bheda (intermittent

distress).^[8]

microbial

load

testing

are

now

feasible

standardisation tools for milk decoctions prepared

by the classical Siddha Dugdha method.

Manikya Pishti — Pharmacological and Classical

Basis

Hridrava, as a term, specifically denotes rapid,

irregular, or forceful cardiac activity as a symptom

within

the

broader Hridroga framework.

Its

Manikya Pishti, prepared from authenticated ruby

aetiology includes excessive physical exertion,

undue fear, grief, emaciation, depletion of Rasa

Dhatu, and Vata aggravation through inappropriate

diet and lifestyle.

(corundum,

Al₂O₃

with

chromium)

through

classical Rasa Shastra Shodhana (purification) and

prolonged trituration, is described in Rasa Ratna

Samuccaya and

as

The

pathway

involves Vata disturbing

the

possessing Hridya (cardiotonic), Medhya (nervine),

normal Spandana (rhythmic contractile activity)

of Hridaya , producing irregular and distressing

sensations^.[4]Modern correlates include functional

arrhythmia, anxiety-related palpitations, vasovagal

episodes, and autonomic dysregulation.

and Balya properties.^[12]

Yadav

(2015)

demonstrated

anxiolytic

and neuroprotective

activity of Manikya Pishti in experimental models,

consistent with its traditional use in psychosomatic

and cardiac anxiety presentations.^[13]

Safety of Pishti formulations requires rigorous

quality assurance. Heavy metal analysis (Pb <10

ppm, Hg <1 ppm, As <3 ppm per AYUSH

standards), particle size verification (<10 microns),

pH, and organoleptic assessment are mandatory

Shaliparni Siddha Dugdha — Textual Basis :

Charaka Samhita (Chikitsa Sthana 28/96) contains

the direct reference: when Vata is aggravated in

the Hridaya,

milk

processed

with Amshumati (Shaliparni) is beneficial^.[6]

This is a targeted, clinically specific prescription

rather than a generalised tonic formula. Shaliparni

(Desmodium gangeticum [L.] DC.) is a constituent

of the classical Dashamula formulation, known for

its Vata-pacifying, Balya (strength-promoting),

and Hridya (cardiac-supportive) properties. ^[9,10]

before

clinical

deployment.^[14]

The

cow

classical Shodhana protocol

employing

milk, Kulattha decoction, cow urine, and lemon

juice over seven cycles must be documented and

reproduced with GMP-level batch records.

Copyright @ : - Dr.Pachore Shreyansh Inter. J.Digno. and Research IJDRMSID0124 |ISSN :2584-2757

177

Volume : 03 Issue : 03

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]

Jyotisha Framework For Cardiac Vulnerability

Surya as Atmakaraka and Cardiac Significator

In Jyotisha literature, Surya is recognised as the

Table 1: Planetary Affliction Scoring System

(PASS) for Cardiac Vulnerability

Component

Indicator

Score

debilitation 2

or

Sun in

(Libra/Tula)

combust

planetary

lord

of

vitality, Atman (individual

self), Prana, and governance of the corporeal

frame. The dictum health is to be sought from the

Sun — encapsulates the solar principle in

maintaining bodily integrity.^[15]

Sun conjunct malefic 2

(Saturn, Rahu, or Ketu)

Solar Afflictions

(Primary)

Sun

aspected

by 2

malefic without benefic

relief

Moon weak or afflicted

(debilitated, or within

72° of Sun)

Mars in or aspecting

fourth house

2

Brihat Parashara Hora Shastra designates Surya as

the Atmakaraka and the signifier of bone structure,

heart, and vital energy, while the fourth house in

the natal chart is identified as the primary cardiac

significator.^[5]

1

Other Cardiac

Indicators

(Secondary)

Malefic occupying

fourth house

1

Fourth house lord weak

or afflicted

1

Varahamihira on Solar Affliction and Cardiac

Disorders :Varahamihira's Brihat Jataka (Adhyaya

2, Shloka 12) that afflictions of the Sun produce,

among other consequences, diseases of the heart

and chest region.^[5]This classical textual statement

provides the Jyotisha basis for examining solar

planetary configuration as a factor in individual

Current Dasha of a

malefic planet

1

Maximum Possible Score

12

Risk categories: Low (0-3), Moderate (4-7), High

(8-12)

Hypotheses to be tested :

 H1 — Participants with High Risk score

(≥8) will show significantly greater baseline

Visual Analog Scale palpitation scores and

Hamilton Anxiety Rating Scale scores than

Low Risk participants (≤3).

susceptibility

to

cardiac

disorders,

including Hridrava. The hypothesis proposed here

is not that astrological factors mechanistically cause

disease, but rather that natal planetary patterns may

reflect constitutional vulnerabilities expressible

through the lens of classical Jyotisha in a manner

susceptible to systematic scoring and correlation

with clinical data.

 H2

remediation) will demonstrate superior

clinical outcomes among High Risk

participants.

 H3 — Planetary Affliction Score will

—

Group

C

(complete

solar

correlate

negatively

with

therapeutic

Proposed Planetary Affliction Scoring System :

A Planetary Affliction Scoring System (PASS) is

proposed (range 0-12) based on established

classical indicators, weighted to prioritise solar

afflictions in accordance with Varahamihira's

observations. The components are set out in Table

1

response

across

all

arms.

Integrative Solar-Centric Therapeutic Rationale

 The conceptual integration proposed here

rests on the shared solar axis identifiable

across Ayurveda and Jyotisha. In Ayurvedic

pharmacology, Shaliparni

(bearing the

Copyright @ : - Dr.Pachore Shreyansh Inter. J.Digno. and Research IJDRMSID0124 |ISSN :2584-2757

178

Volume : 03 Issue : 03

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]

epithet Amshumati,

connoting

solar

Proposed Clinical Validation Protocol

radiance) directly corresponds to classical

prescription

Study Design :

 A prospective, randomised, single-blind,

placebo-controlled, four-arm parallel-group

trial is proposed. The design follows

for Hridrava in Vata aggravation.

Shastra, Manikya (ruby) is specifically

the ratna (gemstone)

is prescribed

In Rasa

CONSORT

CONSORT herbal medicine extension^[17]

2010

standards^[16]

with

identified

as

of Surya and

for Hridya and Medhya applications. In the

Vedic-epic tradition, Aditya Hridaya

applied to the pharmaceutical arms.

 Participants

Stotra (Valmiki Ramayana, Yuddha Kanda

 Inclusion criteria: adults aged 30-60 years;

persistent palpitation complaint of ≥3

months duration; Visual Analog Scale

(VAS) palpitation severity score ≥4/10;

willingness to provide accurate birth date,

time, and place for astrological chart

preparation; written informed consent.

107) represents a structured mantra-based

invocation

of

solar

healing

energies,

employed at a moment of physical and

psychological crisis.

 This solar axis is therefore not merely

symbolic. It reflects a consistent classical

logic: that disturbance of solar energy

 Exclusion

criteria: organic

cardiac

governance

—

whether

interpreted

pathology confirmed by 12-lead ECG and

echocardiography; structural heart disease;

as Atmakaraka affliction

in Jyotisha or

as Vata disorder in the Hridaya in Ayurveda

— is amenable to solar-resonant therapeutic

restoration. The three interventions thus

constitute a coherent layered protocol:

 Layer 1 — Herbal (Shaliparni Siddha

Dugdha): Vata-pacifying, Hridya, nutritive,

cardiac-supportive.

uncontrolled

hypertension

or

diabetes

mellitus; pregnancy or lactation; concurrent

use of cardiac medications or psychiatric

medications that may confound outcomes;

prior adverse reaction to Ayurvedic mineral

preparations.

Sample size: N = 120 (30 per arm), calculated

using G*Power (effect size d = 0.6, power = 0.80, α

= 0.05, with 15% dropout allowance).

 Layer

2

—

Mineral

(Manikya

Pishti): Mineral

fortification, Hridya, Medhya,

solar

Randomisation and Allocation Concealment :

Computer-generated block randomisation (block

size = 4) with allocation concealment via

sequentially numbered, opaque, sealed envelopes

maintained by a biostatistician independent of the

clinical team.

gemological correspondence.

 Layer 3 — Mantric (Aditya Hridaya

Stotra recitation): Psychospiritual, breath-

regulatory,

invocation.

adherence-promoting,

solar

Copyright @ : - Dr.Pachore Shreyansh Inter. J.Digno. and Research IJDRMSID0124 |ISSN :2584-2757

179

Volume : 03 Issue : 03

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]

3. Ayurvedic Symptom Composite Score

Intervention Arms:

(Vata-related domains: sleep, restlessness,

chest discomfort, breathlessness, fatigue; 0-

15 range)

 Group A: Shaliparni Siddha Dugdha 125

ml once daily (morning, empty stomach), 8

weeks.

4. Adverse

event

log

(structured

diary,

 Group B: Shaliparni Siddha Dugdha 125

ml once daily + Manikya Pishti 125 mg

twice daily with honey as anupana, 8

weeks.

reviewed at each visit)

5. Safety bloods: CBC, LFT, RFT, Lipid

Profile (Baseline and Week 8)

Outcome assessors will remain blinded to group

allocation throughout.

 Group C: Shaliparni Siddha Dugdha 125

ml once daily + Manikya Pishti 125 mg

twice daily + guided Aditya Hridaya

Astrological Assessment :

Natal horoscopes (Lagna Kundali) will be prepared

for all 120 participants using verified birth data,

Lahiri Ayanamsa, and standardised software

Stotra recitation

108

times

daily

(standardised audio recording provided), 8

weeks.

(Parashara's

Light

or

Jagannatha

Hora).

A

 Group D (Control): Lifestyle counselling

+ lactose placebo capsule twice daily, 8

weeks.

qualified Jyotisha expert

will score

charts

independently, blinded to clinical data, using

participant codes. The PASS (Table 1) will be

applied consistently. Inter-rater reliability will be

calculated using intraclass correlation coefficient

(ICC) on a 10% subsample independently scored

by a second Jyotisha expert.

Outcome Measure:

Primary outcomes, assessed at Baseline, Week 4,

Week 8, and Week 12 (follow-up):

1. Hamilton Anxiety Rating Scale (HAM-A):

14-item clinician-administered scale, range

0-56

Statistical Analysis :

SPSS v26 and R software will be used. Between-

group comparisons will use one-way ANOVA with

Tukey HSD post-hoc adjustment. Within-group

changes will be analysed by paired t-test. Repeated

measures will be examined via mixed-model

ANOVA (Time × Group interaction).

2. Heart Rate Variability: RMSSD and SDNN

parameters via 5-minute resting ECG

recording

3. Palpitation severity: VAS (0-10 cm) and

weekly frequency count from structured

patient diary

Jyotisha correlations will use Pearson's r between

affliction scores and clinical variables. Multiple

regression will assess predictors of treatment

response. Significance level α = 0.05 throughout;

effect sizes (Cohen's d) will be reported. Intention-

to-treat analysis will be applied using Last

Secondary outcomes:

1. 12-lead ECG parameters (heart rate, PR

interval, QTc, rhythm)

2. WHOQOL-BREF: 26-item quality of life

instrument

Copyright @ : - Dr.Pachore Shreyansh Inter. J.Digno. and Research IJDRMSID0124 |ISSN :2584-2757

180

Volume : 03 Issue : 03

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]

Observation Carried Forward (LOCF) for missing

data.

and stored under the Digital Personal Data

Protection Act 2023.

Pharmaceutical Preparation and Standardisation

Shaliparni Siddha Dugdha :

Discussion :

The present framework addresses a recognised gap

at the intersection of Ayurvedic cardiac care and

Indian Knowledge Systems research methodology.

Existing Ayurvedic cardiovascular literature —

Authenticated Desmodium

gangeticum root

(verified pharmacognostically per API standards)

will be processed with organic A2 cow milk

following Sharangdhara

Khanda 2/161) guidelines. Herb:milk:water ratio

1:8:32, reduced by gentle heating to 1:4

(Siddha state). Standardisation: HPTLC

fingerprinting, alkaloid content, microbial load

Samhita (Madhyama

including

systematic

management,

reviews

and

of Hridroga classification,

pharmacological correlates^{[4,8,18,19,21]}— provides a

sound foundation. What remains absent is a

controlled clinical evaluation specifically targeting

functional palpitations (Hridrava) through a graded

herbo-mineral protocol, and a blinded quantitative

correlation between astrological indicators and

clinical cardiac parameters. The solar-centric

integration proposed here is notable for its internal

conceptual consistency. The therapeutic triad —

Shaliparni (Amshumati), Manikya (Surya's Ratna),

and Aditya Hridaya Stotra — emerges organically

testing^[20]

.

Manikya Pishti: Authenticated ruby specimens

will undergo seven-cycle Shodhana using cow

milk, Kulattha decoction, cow urine, and lemon

juice. Purified material triturated with Gulaba

Jala (rose water) for 72 hours to particle size <10

microns. Quality control: heavy metal analysis (Pb

<10 ppm, Hg <1 ppm, As <3 ppm per AYUSH

standards), pH, organoleptic assessment. Both

preparations under GMP-certified conditions with

full batch documentation.

from

both

classical

pharmacological

texts

and Jyotisha cosmological principles rather than

being assembled arbitrarily. This consistency

strengthens the theoretical basis for the proposed

study. At the same time, several methodological

considerations deserve explicit discussion. Mantra

adherence presents a standardization challenge;

structured guided audio and adherence diaries are

Ethical Compliance :

Institutional Ethics Committee (IEC) approval will

be obtained prior to participant recruitment. The

study will be registered with the Clinical Trials

Registry of India (CTRI) in accordance with

ICMJE requirements. Informed consent will be

proposed, but

objective verification remains

difficult. The placebo comparability between active

and control arms requires careful justification in

available

in

Gujarati,

will be

analysis

Hindi,

explicitly

is

and

English.

informed

research

any

ethics

submission.

The

exclusion

of

Participants

participants with organic cardiac disease is essential

for safety and interpretive clarity but limits

that Jyotisha chart

a

investigation tool and does not constitute medical

prediction or diagnosis. Data will be anonymised

generalisability.

Finally,

interpretation

of

Copyright @ : - Dr.Pachore Shreyansh Inter. J.Digno. and Research IJDRMSID0124 |ISSN :2584-2757

181

Volume : 03 Issue : 03

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]

any Jyotisha correlation

findings

must

remain

sound, and scientifically testable model for

preventive and supportive management of

cautious: statistical association, even if found, does

not establish causation and must be discussed as

hypothesis-generating rather than confirmatory.

The cost-effectiveness dimension — estimated at

approximately INR 50 per day for the integrated

Ayurvedic protocol versus INR 250 and above for

conventional anxiolytics and cardiac medications

— is a relevant public health consideration but

should be formally modeled and documented in any

clinical paper. This framework aligns with the NEP

2020 vision for Indian Knowledge Systems

research and the AYUSH Ministry's emphasis on

evidence-based Ayurvedic practice.^[20]Successful

validation would constitute a meaningful addition

to the evidence base for integrative preventive

cardiology within the IKS paradigm.

functional cardiac disturbances within the Indian

healthcare system.

References :

1.

World Health Organization. Cardiovascular

diseases fact sheet. Geneva: WHO; 2023.

2.

Charaka Samhita, Sutra Sthana 30/3-4. In:

Sharma PV, editor. Charaka Samhita (with

Chakrapani

commentary).

Varanasi:

Chaukhamba Sanskrit Pratishthan; 2008.

3.

4.

Sushruta Samhita, Sharira Sthana 4/31-35.

In: Shastri AD, editor. Sushruta Samhita.

Varanasi: Chaukhamba Sanskrit Sansthan;

2010.

Conclusion :

Jayasuriya HGSV, et al. A Review on

Ayurvedic Concept of Hridroga with

Classical Ayurvedic and Jyotisha texts provide

converging evidence for a solar-centric conceptual

model of Hridrava aetiology, vulnerability, and

Management.

International

Journal

of

Applied Ayurved Research. 2024;7(9):400-

410.

therapeutic

response.

of Shaliparni

Pishti, and Aditya

The

proposed

triadic

Siddha

intervention

5.

6.

7.

Varahamihira. Brihat Jataka, Adhyaya 2,

Dugdha, Manikya

Hridaya

Shloka

12.

In:

Pandit

Sitaram

Jha,

Stotra recitation is internally coherent within this

classical framework. Rigorous clinical validation

through a randomised, controlled, blinded, ethics-

compliant trial design, underpinned by GMP-

translator.

Brihat

Jataka.

Varanasi:

Chaukhamba Sanskrit Pratishthan; 2001.

Charaka Samhita, Chikitsa Sthana 28/96. In:

Sharma PV, editor. Charaka Samhita.

quality

pharmaceutical

preparation

and

reproducible astrological scoring, is necessary

before clinical recommendations can be made. The

present article establishes the conceptual and

Varanasi:

Chaukhamba

Sanskrit

Pratishthan; 2008.

Ashtanga Hridaya, Nidana Sthana 6. In:

Srikantha Murthy KR, translator. Ashtanga

methodological

foundations

for

that

future

investigation. This framework may ultimately

contribute a culturally authentic, methodologically

Copyright @ : - Dr.Pachore Shreyansh Inter. J.Digno. and Research IJDRMSID0124 |ISSN :2584-2757

182

Volume : 03 Issue : 03

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]

Hridayam. Varanasi: Krishnadas Academy;

Pharmacopoeia of India. New Delhi:

Government of India; 2016.

2004.

8.

9.

Parveen T, Jadhav G, Sharma R, Sevatkar

15. Parashara Muni. Brihat Parashara Hora

Shastra, Adhyaya 12-14. In: Santhanam R,

translator. Brihat Parashara Hora Shastra.

New Delhi: Ranjan Publications; 2002.

BK. A conceptual study of Hridroga in

context of modern era. Journal of Ayurveda

and

Integrated

Medical

Sciences.

2023;8(2):178-185.

16. Schulz

KF, Altman DG, Moher

D.

Hebbar

JV.

Shaliparni

(Desmodium

CONSORT

2010 Statement: Updated

gangeticum) – Ayurvedic uses, dose, side

effects. Easy Ayurveda. 2012. Available

from: https://www.easyayurveda.com

Guidelines for Reporting Parallel Group

Randomised Trials. BMJ. 2010;340:c332.

17. Gagnier JJ, Boon H, Rochon P, et al.

Reporting randomised, controlled trials of

10. Sharma PC, Yelne MB, Dennis TJ, editors.

Database on Medicinal Plants Used in

Ayurveda. Volume 2. New Delhi: Central

herbal

interventions:

an

elaborated

CONSORT statement. Ann Intern Med.

2006;144(5):364-367.

Council

for

Research

in

Ayurvedic

Sciences; 2001.

18. Khot VD, et al. Cardiovascular perspective

of Hridaya in Ayurveda. World Journal of

Pharmaceutical and Medical Research.

2023;9(11):01-07.

11. Mridula MK, Ansary PY. An insight into

the cardioprotective properties of

Prisniparni (Desmodium gangeticum [L.]

DC.) through its secondary metabolites.

Kerala Journal of Ayurveda. 2023;2(1):45-

52.

19. Joglekar AA, Vyas MK, Bhojani MK.

Recent

advances

in

diagnosis

and

management of ischemic heart diseases in

perspective of contemporary and Ayurveda

medicine: a comprehensive review. Journal

12. Rasa Ratna Samuccaya, Chapter 4. In:

Mishra SN, editor. Rasa Ratna Samuccaya

(Commentary).

Varanasi:

Chaukhamba

of

Indian

System

of

Medicine.

Sanskrit Sansthan; 2011.

2023;11(1):7-15.

13. Yadav

RS.

In

Vivo

Evaluation

of

20. Mukherjee PK, Venkatesh M, Gantait A.

Ayurveda in modern medicine:

development and constrains. In: Ramawat

KG, Merillon JM, editors. Bioactive

Neuroprotective Activity of Manikya Pishti.

International Journal of Innovative Research

and Advanced Studies. 2015;2(10):8-13.

Molecules and Medicinal Plants. Berlin:

Springer; 2008. p. 217-238.

14. Ministry of AYUSH, Government of India.

Pharmacopoeia

of

India:

Ayurvedic

Copyright @ : - Dr.Pachore Shreyansh Inter. J.Digno. and Research IJDRMSID0124 |ISSN :2584-2757

183

Volume : 03 Issue : 03

INTERNATIONAL JOURNAL OF DIAGNOSTICS AND RESEARCH [ISSN No.: 2584-2757]

21. Patwardhan B, Warude D, Pushpangadan P,

Bhatt N. Ayurveda and traditional Chinese

medicine: a comparative overview. eCAM.

2005;2(4):465-473.

ISSN: 2584-2757

DOI : https://doi.org/10.5281/zenodo.19613930

Dr. Pahore Shreyansh Inter. J.Digno. and Research

This work is licensed under Creative

Commons Attribution 4.0 License

Acknowledgements: The authors acknowledge the

academic guidance received from the Department

Submission Link : http://www.ijdrindia.com

of Rachana

of Rasashastra evam Bhaishajya Kalpana, Nootan

Ayurvedic College and Research Centre,

Sankalchand Patel University, Visnagar. No

Sharir and

the

Department

Benefits of Publishing with us

Fast peer review process

external funding was received for this review

manuscript. Future clinical validation work will be

supported through the IKS BG Samvardhan Yojana

Programme of the Indian Knowledge Systems

Division, Ministry of Education, Government of

India

Global archiving of the articles

Unrestricted open online access

Author retains copyright

Unique DOI for all articles

https://ijdrindia.com

Funding Statement: No funding was received for

the preparation of this review article. The proposed

clinical protocol is intended to be submitted

separately

acknowledgement.

Ethical Statement: This

with

appropriate

funding

manuscript

is

a

conceptual review article and proposed clinical

protocol. No new participant data are reported

herein. No ethics approval was required for this

article. Future clinical trial implementation will

require IEC approval and CTRI registration prior to

commencement.

Declaration :

Conflict of Interest : None

Copyright @ : - Dr.Pachore Shreyansh Inter. J.Digno. and Research IJDRMSID0124 |ISSN :2584-2757

184